Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jishu Pagag

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Biomolecular Structure & Dynamics|December 17, 2024
Computational design and validation of small molecule inhibitors for type III phosphatidylinositol-4-kinase alpha, a hepatitis C drug targetJishu Pagag, Priyanka Andola, Laxman Durgam, et al.
Journal of Biomolecular Structure & Dynamics|April 1, 2026
Computational validation of inhibitors for human phosphatidylinositol 4-phosphate 5-kinase-type 1 α protein implicated in cancerPriyanka Andola, Jishu Pagag, Durgam Laxman, et al.
Structural Chemistry|July 11, 2022
Fragment-based inhibitor design for SARS-CoV2 main proteasePriyanka Andola, Jishu Pagag, Durgam Laxman, et al.
Journal of Biomolecular Structure & Dynamics|September 15, 2023
Mutational analyses, pharmacophore-based inhibitor design and in silico validation for Zika virus NS3-helicaseLaxman Durgam, Jishu Pagag, Y Indra Neela, et al.
Scientific Reports|October 1, 2025
Application of chemical similarity and bioisosteres to find allosteric inhibitors of type 2 lipid kinase γPriyanka Andola, Jishu Pagag, Gatta K R S Naresh, et al.
Heliyon|May 7, 2024
Design, synthesis, <i>in-silico</i> studies and apoptotic activity of novel amide enriched 2-(1<i>H</i>)- quinazolinone derivativesNaganjaneyulu Gariganti, Anjaneyulu Bandi, K R S Naresh Gatta, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Biomolecular Structure & Dynamics|December 17, 2024
Computational design and validation of small molecule inhibitors for type III phosphatidylinositol-4-kinase alpha, a hepatitis C drug targetJishu Pagag, Priyanka Andola, Laxman Durgam, et al.
Journal of Biomolecular Structure & Dynamics|April 1, 2026
Computational validation of inhibitors for human phosphatidylinositol 4-phosphate 5-kinase-type 1 α protein implicated in cancerPriyanka Andola, Jishu Pagag, Durgam Laxman, et al.
Structural Chemistry|July 11, 2022
Fragment-based inhibitor design for SARS-CoV2 main proteasePriyanka Andola, Jishu Pagag, Durgam Laxman, et al.
Journal of Biomolecular Structure & Dynamics|September 15, 2023
Mutational analyses, pharmacophore-based inhibitor design and in silico validation for Zika virus NS3-helicaseLaxman Durgam, Jishu Pagag, Y Indra Neela, et al.
Scientific Reports|October 1, 2025
Application of chemical similarity and bioisosteres to find allosteric inhibitors of type 2 lipid kinase γPriyanka Andola, Jishu Pagag, Gatta K R S Naresh, et al.
Heliyon|May 7, 2024
Design, synthesis, <i>in-silico</i> studies and apoptotic activity of novel amide enriched 2-(1<i>H</i>)- quinazolinone derivativesNaganjaneyulu Gariganti, Anjaneyulu Bandi, K R S Naresh Gatta, et al.
Pageof 1